Abstract: The present invention refers to pharmaceutical, dietary and/or nutraceutical orosoluble and/or effervescent compositions for oral use containing at least a salt of S-adenosyl methionine (SAMe), combined with physiologically acceptable excipients and optionally additional active ingredients. In particular the invention refers to compositions with high palatability formulated in tablet, capsule or granules. The present invention also refers to the use of at least a salt of SAMe combined with physiologically acceptable excipients and optionally further active ingredients for treating, human or veterinarian, neuropsychiatric, osteoarticular or hepatic diseases.

Abstract: The present invention refers to pharmaceutical, dietary and/or nutraceutical orosoluble and/or effervescent compositions for oral use containing at least a salt of S-adenosyl methionine (SAMe), combined with physiologically acceptable excipients and optionally additional active ingredients. In particular the invention refers to compositions with high palatability formulated in tablet, capsule or granules. The present invention also refers to the use of at least a salt of SAMe combined with physiologically acceptable excipients and optionally further active ingredients for treating, human or veterinarian, neuropsychiatric, osteoarticular or hepatic diseases.

Abstract: A foodstuff composition is described which contains from 50 to 90% by weight of inulin or fructooligosaccharides, from 10 to 40% by weight of gelling fibres, and from 1 to 10% by weight of water-insoluble fibres. This composition may be mixed with soft wheat flour and/or durum wheat flour and used as an alternative to flour for the preparation of food products for the purpose of reducing the glycaemic peak.

Abstract: The present invention relates to solid dietary and/or nutraceutic pharmaceutical compositions for oral use based on SAMe, or salts thereof, in combination with inositol and/or derivatives thereof and to a process for their preparation. The present invention relates to a method of stabilising a solid composition for oral use based on SAMe or salts thereof, making use of inositol and/or derivatives thereof with the addition of magnesium oxide.

Abstract: The present invention relates to solid dietary and/or nutraceutic pharmaceutical compositions for oral use based on SAMe, or salts thereof, in combination with inositol and/or derivatives thereof and to a process for their preparation. The present invention relates to a method of stabilising a solid composition for oral use based on SAMe or salts thereof, making use of inositol and/or derivatives thereof with the addition of magnesium oxide. The present invention also relates to the use of SAMe, or salts thereof, in combination with inositol and/or derivatives thereof with the possible further addition of melatonine, St. John's Wort and/or lemon balm for the treatment of depressive states and/or panic syndromes.

Abstract: A granular formulation is described, said formulation being based on granules formed by an inner core essentially consisting of at least one pure active component, mixtures of active components or mixtures thereof with suitable inert excipients or pharmaceutically acceptable salts thereof in an amount of between 50% and 90% by weight of the formulation, and by an outer coating essentially consisting of hydrogenated vegetable fats in an amount of between 10% and 50% by weight of the formulation. An example of the selected active component is S-adenosylmethionine. The product according to said formulation can be used, for example, also in the veterinary field for administration by mixing with the feed.

Abstract: A foodstuff composition is described which contains form 50 to 90% by weight of inulin or fructooligosaccharides, from 10 to 40% by weight of gelling fibres, and from 1 to 10% by weight of water-insoluble fibres. This composition may be mixed with soft wheat flour and/or durum wheat flour and used as an alternative to flour for the preparation of food products for the purpose of reducing the glycaemic peak.

Abstract: The present invention relates to solid dietary and/or nutraceutic pharmaceutical compositions for oral use based on SAMe, or salts thereof, in combination with inositol and/or derivatives thereof and to a process for their preparation. The present invention relates to a method of stabilising a solid composition for oral use based on SAMe or salts thereof, making use of inositol and/or derivatives thereof with the addition of magnesium oxide.

Abstract: An edulcorating composition containing 5 to 20% by weight of inulin or fruitoligosaccharides, from 2 to 15% by weight of jellying fibres, 0.5 to 5% by weight of cellulose and 60 to 92.5% by weight of monosaccharides or disaccharides.

Abstract: A novel formulation for oral use containing at least one active principle with a pharmaceutical, dietary or alimentary action, in combination with at least one fat in an amount of between 5 and 30%, relative to the weight of the formulation; this formulation allows the slow release, over time, of the active principle under physiological conditions which simulate the digestive processes which normally take place in the stomach.

Abstract: An edulcorating soluble composition containing from 50 to 98% by weight of at least a non gelating alimentary fiber such as insulin and from 0.2 to 50% by weight of at least one natural or synthetic sweetener. The composition has an apparent density of from 400 to 600 g/l. The composition may be added to hot or cold drinks/beverages, a convenient way to increase fiber in the diet.

Abstract: An edulcorating soluble composition containing from 50 to 98% by weight of at least a non gelating alimentary fiber such as insulin and from 0.2 to 50% by weight of at least one natural or synthetic sweetener. The composition has an apparent density of from 400 to 600 g/l. The composition may be added to hot or cold drinks/beverages, a convenient way to increase fiber in the diet.

Abstract: Chewing gum tablets and their methods of preparation are disclosed. The gum tablets contain a mixture of chewing gum base and sugary microgranules with an additive agent and an active ingredient adsorbed onto their surface. A lacquer coating on the tablet contains cellulose and polyethlene glycols. The sugary microgranules are delayed release coated particles. The chewing gums act as vehicles for active ingredients. These active ingredients may be used alone or in combination in normal physical form in the form of coated microspheres.